Kentucky AG Settles OxyContin, Risperdal Suits For $39.5M

By Brandon Lowrey (December 23, 2015, 3:17 PM EST) -- Purdue Pharma LP and Johnson & Johnson will pay a combined $39.5 million to settle respective lawsuits over the narcotic OxyContin and antipsychotic Risperdal brought by the state of Kentucky, its attorney general said Wednesday, ending nearly nine years of litigation.

Under the terms of the settlements, Purdue will pay $24 million, and Johnson & Johnson will pay $15.5 million. Both cases were filed in state courts in 2007 and settled Tuesday, according to a statement from the Kentucky attorney general's office.

"These companies engaged in reckless behavior that put our citizens at risk," Attorney General Jack Conway said. "Both companies...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!